BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26090754)

  • 1. Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men.
    Ketlogetswe KS; McKibben R; Jacobson LP; Li X; Dobs AS; Budoff M; Witt MD; Palella FJ; Kingsley L; Margolick JB; Post WS; Brown TT
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):362-9. PubMed ID: 26090754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study.
    Kelesidis T; Kendall MA; Yang OO; Hodis H; Currier JS
    AIDS Res Hum Retroviruses; 2013 Jun; 29(6):938-48. PubMed ID: 23351153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between HIV infection and subclinical coronary atherosclerosis.
    Post WS; Budoff M; Kingsley L; Palella FJ; Witt MD; Li X; George RT; Brown TT; Jacobson LP
    Ann Intern Med; 2014 Apr; 160(7):458-67. PubMed ID: 24687069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosis.
    Brener M; Ketlogetswe K; Budoff M; Jacobson LP; Li X; Rezaeian P; Razipour A; Palella FJ; Kingsley L; Witt MD; George RT; Post WS
    AIDS; 2014 Jul; 28(11):1635-44. PubMed ID: 24809732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor activator of nuclear factor-κB ligand (RANKL) and its relationship to coronary atherosclerosis in HIV patients.
    Hwang JJ; Wei J; Abbara S; Grinspoon SK; Lo J
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):359-63. PubMed ID: 22842843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low thigh muscle mass is associated with coronary artery stenosis among HIV-infected and HIV-uninfected men: The Multicenter AIDS Cohort Study (MACS).
    Tibuakuu M; Zhao D; Saxena A; Brown TT; Jacobson LP; Palella FJ; Witt MD; Koletar SL; Margolick JB; Guallar E; Korada SKC; Budoff MJ; Post WS; Michos ED
    J Cardiovasc Comput Tomogr; 2018; 12(2):131-138. PubMed ID: 29396194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between circulating serum osteoprotegerin and total receptor activator of nuclear κ-B ligand levels, triglycerides, and coronary calcification in postmenopausal women.
    Poornima IG; Mackey RH; Buhari AM; Cauley JA; Matthews KA; Kuller LH
    Menopause; 2014 Jul; 21(7):702-10. PubMed ID: 24473535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and progression of coronary artery calcium in HIV-infected and HIV-uninfected men.
    Kingsley LA; Deal J; Jacobson L; Budoff M; Witt M; Palella F; Calhoun B; Post WS
    AIDS; 2015 Nov; 29(18):2427-34. PubMed ID: 26558542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GlycA, a novel inflammatory marker, is associated with subclinical coronary disease.
    Tibuakuu M; Fashanu OE; Zhao D; Otvos JD; Brown TT; Haberlen SA; Guallar E; Budoff MJ; Palella FJ; Martinson JJ; Akinkuolie AO; Mora S; Post WS; Michos ED
    AIDS; 2019 Mar; 33(3):547-557. PubMed ID: 30475263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frailty and subclinical coronary atherosclerosis: The Multicenter AIDS Cohort Study (MACS).
    Korada SKC; Zhao D; Tibuakuu M; Brown TT; Jacobson LP; Guallar E; Bolan RK; Palella FJ; Margolick JB; Martinson JJ; Budoff MJ; Post WS; Michos ED
    Atherosclerosis; 2017 Nov; 266():240-247. PubMed ID: 28886899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality.
    Lieb W; Gona P; Larson MG; Massaro JM; Lipinska I; Keaney JF; Rong J; Corey D; Hoffmann U; Fox CS; Vasan RS; Benjamin EJ; O'Donnell CJ; Kathiresan S
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1849-54. PubMed ID: 20448212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men.
    Ketlogetswe KS; Post WS; Li X; Palella FJ; Jacobson LP; Margolick JB; Kingsley LA; Witt MD; Dobs AS; Budoff MJ; Brown TT
    AIDS; 2014 Mar; 28(6):901-9. PubMed ID: 24401646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does osteoprotegerin or receptor activator of nuclear factor-kappaB ligand mediate the association between bone and coronary artery calcification?
    Bakhireva LN; Laughlin GA; Bettencourt R; Barrett-Connor E
    J Clin Endocrinol Metab; 2008 May; 93(5):2009-12. PubMed ID: 18319315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between lipids and subclinical coronary atherosclerosis.
    Whelton SP; Deal JA; Zikusoka M; Jacobson LP; Sarkar S; Palella FJ; Kingsley L; Budoff M; Witt MD; Brown TT; Post WS
    AIDS; 2019 May; 33(6):1053-1061. PubMed ID: 30946159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003.
    Semb AG; Ueland T; Aukrust P; Wareham NJ; Luben R; Gullestad L; Kastelein JJ; Khaw KT; Boekholdt SM
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):975-80. PubMed ID: 19325145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cross-sectional Study of the Association Between Chronic Hepatitis C Virus Infection and Subclinical Coronary Atherosclerosis Among Participants in the Multicenter AIDS Cohort Study.
    McKibben RA; Haberlen SA; Post WS; Brown TT; Budoff M; Witt MD; Kingsley LA; Palella FJ; Thio CL; Seaberg EC
    J Infect Dis; 2016 Jan; 213(2):257-65. PubMed ID: 26216904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
    Ahmed S; Sobh R
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell receptor activator of nuclear factor-κB ligand/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts.
    Titanji K; Vunnava A; Foster A; Sheth AN; Lennox JL; Knezevic A; Shenvi N; Easley KA; Ofotokun I; Weitzmann MN
    AIDS; 2018 Apr; 32(7):885-894. PubMed ID: 29424771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study.
    Stern A; Laughlin GA; Bergstrom J; Barrett-Connor E
    Eur J Endocrinol; 2007 May; 156(5):555-62. PubMed ID: 17468191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection is associated with an increased prevalence of coronary noncalcified plaque among participants with a coronary artery calcium score of zero: Multicenter AIDS Cohort Study (MACS).
    Metkus TS; Brown T; Budoff M; Kingsley L; Palella FJ; Witt MD; Li X; George RT; Jacobson LP; Post WS
    HIV Med; 2015 Nov; 16(10):635-9. PubMed ID: 25968104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.